Worth reading
44Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
68
¥100 million (year-on-year increase in operating profit)Wording
Conditional
How definitive the wording is.Contents of this document
Presentation materials for financial resultsFirst quarter of the fiscal year ending March 20275 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales2,230 Hundreds of millions of yen+12.3%
Operating profit149 Hundreds of millions of yen+83.1%
Ordinary income138 Hundreds of millions of yen+127.7%
Net income¥89 100 million +109.8%quarterly net income attributable to owners of the parent
Operating profit margin6.7%, +2.6 percentage points year on year
Results for the three months of the current quarter
Net Sales
2,230 Hundreds of millions of yen
Operating profit
149 Hundreds of millions of yen
Ordinary income
138 Hundreds of millions of yen
Net income
¥89 100 million quarterly net income attributable to owners of the parent
Full-year earnings forecast
Net Sales
8,200 Hundreds of millions of yen
Operating profit
360 Hundreds of millions of yen
Ordinary income
320 Hundreds of millions of yen
Net income
¥315 100 million net income attributable to owners of the parent
Operating profit margin
4.4 %
Earnings per share
¥523.04
Dividend per share
¥210
What the company explained in this material
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
Average exchange rate during the period (US dollar)
¥150
Average exchange rate during the period (euro)
¥170
Domestic naphtha
¥120,000
New initiatives
- Expanding sales through collaboration with Cemedine
- Development of mass-production technology for tandem perovskite solar cells
- Adoption of Green Planet in Shimano lures
- Adoption by local governments of biodegradable artificial turf jointly developed with Mizuno
Segment results
- Material SUNet Sales944 Hundreds of millions of yen (YoY +14.7%)Operating profit109 Hundreds of millions of yen (YoY +73.3%)
- Quality of Life SUNet Sales538 Hundreds of millions of yen (YoY +11.1%)Operating profit70 Hundreds of millions of yen (YoY +34.5%)
- Health Care SUNet Sales220 Hundreds of millions of yen (YoY +20.5%)Operating profit35 Hundreds of millions of yen (YoY +11.3%)
- Nutrition SUNet Sales524 Hundreds of millions of yen (YoY +6.3%)Operating profit34 Hundreds of millions of yen (YoY +25.5%)
- OtherNet Sales3 Hundreds of millions of yen (YoY +5.1%)Operating profit1 Hundreds of millions of yen (YoY +9.1%)
Financial targets
ROE
Actual results6.4 %
Forecast6.2 %
Equity ratio
Actual results52 %
End of period51.3 %
Debt-to-equity ratio
Actual results0.42 times
End of period0.45 times
Annual Dividend
¥210 per share
| Item | Details |
|---|---|
| Document type | Presentation materials for financial results |
| Fiscal Period Covered | First quarter of the fiscal year ending March 2027 |
| Net Sales | 2,230 Hundreds of millions of yen (YoY +12.3%) |
| Operating profit | 149 Hundreds of millions of yen (YoY +83.1%) |
| Ordinary income | 138 Hundreds of millions of yen (YoY +127.7%) |
| Net income | ¥89 100 million (quarterly net income attributable to owners of the parent) (YoY +109.8%) |
| Operating profit margin | 6.7%, +2.6 percentage points year on year |
| Results for the three months of the current quarter | Net Sales 2,230 Hundreds of millions of yen / Operating profit 149 Hundreds of millions of yen / Ordinary income 138 Hundreds of millions of yen / Net income ¥89 100 million (quarterly net income attributable to owners of the parent) |
| Full-year earnings forecast | Net Sales 8,200 Hundreds of millions of yen / Operating profit 360 Hundreds of millions of yen / Ordinary income 320 Hundreds of millions of yen / Net income ¥315 100 million (net income attributable to owners of the parent) / Operating profit margin 4.4 % / Earnings per share ¥523.04 / Dividend per share ¥210 |
| Segment results | Segment Material SU / Net Sales 944 Hundreds of millions of yen (YoY +14.7%) / Operating profit 109 Hundreds of millions of yen (YoY +73.3%), Segment Quality of Life SU / Net Sales 538 Hundreds of millions of yen (YoY +11.1%) / Operating profit 70 Hundreds of millions of yen (YoY +34.5%), Segment Health Care SU / Net Sales 220 Hundreds of millions of yen (YoY +20.5%) / Operating profit 35 Hundreds of millions of yen (YoY +11.3%), Segment Nutrition SU / Net Sales 524 Hundreds of millions of yen (YoY +6.3%) / Operating profit 34 Hundreds of millions of yen (YoY +25.5%), Segment Other / Net Sales 3 Hundreds of millions of yen (YoY +5.1%) / Operating profit 1 Hundreds of millions of yen (YoY +9.1%) |
| Assumptions Underlying the Business Outlook | Average exchange rate during the period (US dollar) ¥150 / Average exchange rate during the period (euro) ¥170 / Domestic naphtha ¥120,000 |
| Financial targets | ROE Actual results 6.4 % / Forecast 6.2 % / Equity ratio Actual results 52 % / End of period 51.3 % / Debt-to-equity ratio Actual results 0.42 times / End of period 0.45 times |
| Annual Dividend | ¥210 per share |
| New initiatives | Expanding sales through collaboration with Cemedine, Development of mass-production technology for tandem perovskite solar cells, Adoption of Green Planet in Shimano lures, Adoption by local governments of biodegradable artificial turf jointly developed with Mizuno |
Items this document does not state (17)
Gross Profit MarginSelling, general and administrative expensesProgress against full-year forecastSelf-assessment against the planBreakdown of Factors Affecting the ChangeKey KPIsUnit price and quantity metricsNumber of stores and locationsNumber of employeesRisk amount incorporated into the outlookMedium-term management plan targetsPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company cited rigorous efforts to ensure stable supply, price revisions, a shift toward high-value-added products, expanded overseas sales, the effects of M&A, and increased sales of reduced-sugar Q10 products as factors behind the increases in revenue and operating profit.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.